Docking domains and substrate-specificity determination for MAP kinases

Trends in Biochemical Sciences

Volumn 25, Issue 9, 2000, Pages 448-453

  Sharrocks, Andrew D ^a   Yang, Shen His ^a   Galanis, Alex ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; ONCOPROTEIN; PROTEIN C JUN; PROTEIN V JUN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; BINDING SITE; ENZYME BINDING; ENZYME SPECIFICITY; ENZYME STRUCTURE; EVOLUTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; EVOLUTION, MOLECULAR; MAP KINASE SIGNALING SYSTEM; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN ISOFORMS; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; SUBSTRATE SPECIFICITY; TRANSCRIPTION FACTORS;

EUKARYOTA;

EID: 0034284131     PISSN: 09680004     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0004(00)01627-3     Document Type: Review

References (35)

1. Robinson M.J., Cobb M.H. Mitogen-activated protein kinase pathways. Curr. Opin. Cell Biol. 9:1997;180-186.
2. Whitmarsh A.J., Davis R.J. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. 74:1996;589-607.
3. Madhani H.D., Fink G.R. The riddle of MAP kinase signaling specificity. Trends Genet. 14:1998;151-155.
4. Whitmarsh A.J., Davis R.J. Structural organization of MAP-kinase signaling modules by scaffold proteins in yeast and mammals. Trends Biochem. Sci. 23:1998;481-485.
5. Hibi M.et al. Identification of an oncoprotein- and UV-responsive protein kinase that binds and potentiates the c-Jun activation domain. Genes Dev. 7:1993;2135-2148.
6. Dai T.et al. Stress-activated protein kinases bind directly to the delta domain of c-Jun in resting cells. implications for repression of c-Jun function Oncogene. 10:1995;849-855.
7. Karin M. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol. Chem. 270:1995;16483-16486.
8. Gupta S.et al. Transcription factor ATF2 regulation by the JNK signal transduction pathway. Science. 267:1995;389-393.
9. Livingstone C.et al. ATF-2 contains a phosphorylation-dependent transcriptional activation domain. EMBO J. 14:1995;1785-1797.
10. Yang S.-H.et al. The Elk-1 ETS-domain transcription factor contains a MAP kinase targeting motif. Mol. Cell. Biol. 18:1998;710-720.
11. Yang S.H.et al. Targeting of p38 mitogen-activated protein kinases to MEF2 transcription factors. Mol. Cell. Biol. 19:1999;4028-4038.
12. Gupta S.et al. Selective interaction of JNK protein kinase isoforms with transcription factors. EMBO J. 15:1996;2760-2770.
13. Yang S.-H.et al. Differential targeting of MAP kinases to the ETS-domain transcription factor Elk-1. EMBO J. 17:1998;1740-1749.
14. Kallunki T.et al. c-Jun can recruit JNK to phosphorylate dimerization partners via specific docking interactions. Cell. 87:1996;929-939.
15. MacKenzie S.J.et al. ERK2 MAP kinase binding, phosphorylation and regulation of PDE4D cAMP specific phosphodiesterases. the involvement of C-terminal docking sites and N-terminal UCR regions J. Biol. Chem. 275:2000;16609-16617.
16. Dickens M.et al. A cytoplasmic inhibitor of the JNK signal transduction pathway. Science. 277:1997;693-696.
17. Pulido R.et al. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif. EMBO J. 17:1998;7337-7350.
18. Zuniga A.et al. Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm. J. Biol. Chem. 274:1999;21900-21907.
19. Bardwell L., Thorner J. A conserved motif at the amino termini of MEKs might mediate high-affinity interaction with the cognate MAP KINASEs. Trends Biochem. Sci. 21:1996;373-374.
20. Tanoue T.et al. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell. Biol. 2:2000;110-116.
21. Xu B-E.et al. The N-terminal ERK-binding site of MEK1 is required for efficient feedback phosphorylation by ERK2 in vitro and ERK activation in vivo. J. Biol. Chem. 274:1999;34029-34035.
22. Gavin A.C., Nebreda A.R. A MAP kinase docking site is required for phosphorylation and activation of p90(rsk)/MAPKAP kinase-1. Curr. Biol. 9:1999;281-284.
23. Smith J.A.et al. Identification of an extracellular signal-regulated kinase (ERK) docking site in ribosomal S6 kinase, a sequence critical for activation by ERK in vivo. J. Biol. Chem. 274:1999;2893-2898.
24. May G.H.et al. Analysis of the interaction between c-Jun and c-Jun N-terminal kinase in vivo. J. Biol. Chem. 273:1998;33429-33435.
25. Jacobs D.et al. Gain-of-function mutations in the Caenorhabditis elegans lin-1 ETS gene identify a C-terminal regulatory domain phosphorylated by ERK MAP kinase. Genetics. 149:1998;1809-1822.
26. Jacobs D.et al. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev. 13:1999;163-175.
27. Whitmarsh A.J.et al. A mammalian scaffold complex that selectively mediates MAP kinase activation. Science. 281:1998;1671-1674.
28. Yang C.C.et al. Interaction of myocyte enhancer factor 2 (MEF2) with a mitogen-activated protein kinase, ERK5/BMK1. Nucleic Acids Res. 26:1998;4771-4777.
29. May G.H.et al. An oncogenic mutation uncouples the v-Jun oncoprotein from positive regulation by the SAPK/JNK pathway in vivo. Curr. Biol. 8:1998;117-120.
30. Zhan X.L., Guan K.L. A specific protein-protein interaction accounts for the in vivo substrate selectivity of Ptp3 towards the Fus3 MAP kinase. Genes Dev. 13:1999;2811-2827.
31. Kallunki T.et al. JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev. 8:1994;2996-3007.
32. Gum R.J., Young P.R. Identification of two distinct regions of p38 MAP kinase required for substrate binding and phosphorylation. Biochem. Biophys. Res. Commun. 266:1999;284-289.
33. Camps M.et al. Catalytic activation of the phosphatase MKP-3 by ERK2 mitogen-activated protein kinase. Science. 280:1998;1262-1265.
34. Knighton D.R.et al. Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase. Science. 253:1991;414-420.
35. Holland P.M., Cooper J.A. Protein modification. docking sites for kinases Curr. Biol. 9:1999;329-331.